Collegium Pharmaceutical (COLL) Cash from Investing Activities (QoQ) (2015 - 2026)
Collegium Pharmaceutical (COLL) Cash from Investing Activities (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Collegium Pharmaceutical | 887.15 Mn | 737.84 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30,990.66% |
| Mar 31, 2026 | 108.11% |
| Dec 31, 2025 | 34.98% |
| Sep 30, 2025 | -958.94% |
| Jun 30, 2025 | 69.89% |
| Mar 31, 2025 | 17.70% |
| Dec 31, 2024 | 95.28% |
| Sep 30, 2024 | -2,695.45% |
| Jun 30, 2024 | 50.87% |
| Mar 31, 2024 | 27.77% |
| Dec 31, 2023 | -556.65% |
| Sep 30, 2023 | 90.84% |
| Jun 30, 2023 | -23,602.84% |
| Mar 31, 2023 | 81.28% |
| Dec 31, 2022 | -731.86% |
| Sep 30, 2022 | 75.49% |
| Jun 30, 2022 | 99.92% |
| Mar 31, 2022 | -111,002.33% |
| Dec 31, 2021 | -86.59% |
| Sep 30, 2021 | 61.93% |